市場調査レポート

商品コード

1522921

腫れた膝治療の市場規模、シェア、成長分析：タイプ別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Swollen Knee Treatment Market Size, Share, Growth Analysis, By Type, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年07月20日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

腫れた膝治療の市場規模は、2022年に20億米ドルとなり、2023年の20億9,000万米ドルから、2031年までには29億7,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは4.5％で成長する見通しです。

腫れた膝治療市場は、非外科的ヘルスケアへの顕著なシフトにより、成長軌道の障害に遭遇する可能性があります。この動向は、侵襲性が低く非侵襲的な治療を好む傾向が広まったことを反映して、従来の手術よりも治癒様式を支持するものです。膝関節形成術のような手術に関連する潜在的なリスクや合併症に対する意識の高まりが、患者の選好の変化に寄与しています。人々は、リスクを軽減し、回復期間を短縮しながら、同等の有効性を提供する代替手段を求めるようになってきています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5企業の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Pfizer Inc.（United States）
Johnson & Johnson（United States）
Novartis AG（Switzerland）
GlaxoSmithKline plc（United Kingdom）
Merck & Co., Inc.（United States）
Bayer AG（Germany）
Sanofi（France）
Eli Lilly and Company（United States）
Abbott Laboratories（United States）
AstraZeneca plc（United Kingdom）
Bristol-Myers Squibb Company（United States）
Boehringer Ingelheim GmbH（Germany）
AbbVie Inc.（United States）
Amgen Inc.（United States）
F. Hoffmann-La Roche AG（Switzerland）
Teva Pharmaceutical Industries Ltd.（Israel）
Mylan N.V.（United States）
Novo Nordisk A/S（Denmark）
Allergan plc（United States）
Takeda Pharmaceutical Company Limited（Japan）

Product Code: SQMIG35A2820

Swollen Knee Treatment Market size was valued at USD 2.00 billion in 2022 and is poised to grow from USD 2.09 billion in 2023 to USD 2.97 billion by 2031, growing at a CAGR of 4.5% in the forecast period (2024-2031).

The swollen knee treatment market might encounter obstacles in its growth path due to a noticeable shift towards non-surgical healthcare options. This trend advocates for healing modalities over traditional surgery, reflecting a broader preference for less invasive and non-invasive treatments. Heightened awareness of potential risks and complications linked to procedures like knee arthroplasty contributes to this change in patient preferences. People are increasingly seeking alternatives that offer comparable efficacy with reduced risks and shorter recovery periods.

Top-down and bottom-up approaches were used to estimate and validate the size of the Swollen Knee Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Swollen Knee Treatment Market Segmental Analysis

The swollen knee treatment market is segmented based on type, end user, and region. Based on type, the market is segmented into Medications (Opioids, Corticosteroids, Others), Patient-controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine, Surgery (Arthrocentesis, Arthroscopy, Knee Replacement). Based on end user, the market is segmented into hospitals, designated clinics, ambulatory surgical centers, and others. Based on region, the swollen knee treatment market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Drivers of the Swollen Knee Treatment Market

The escalating healthcare expenses in the market create substantial prospects for enhancing accessibility, innovation, and efficiency within the dental care industry. Improved income distribution enables better healthcare services, cutting-edge technology, and enhanced medical treatments. However, to fully capitalize on these opportunities, it is crucial to tackle challenges such as uneven distribution, ethical considerations, and financial viability. Implementing appropriate and well-planned sustainability measures is essential to ensure that increased healthcare expenditure benefits all segments of the population, thereby reducing disparities in access to dental care.

Restraints in the Swollen Knee Treatment Market

Advanced medical procedures like knee replacement surgery often pose financial obstacles that restrict access for patients with limited resources. The expenses related to knee replacement surgery encompass various elements such as preoperative assessments, surgical techniques, postoperative care, and rehabilitation, making access to this beneficial treatment limited. The financial challenges associated with advanced procedures like knee replacement surgery highlight the significance of addressing healthcare disparities and ensuring equitable access to treatment for all.

Market Trends of the Swollen Knee Treatment Market

Ongoing advancements in medical device technology, particularly in knee-related solutions, offer significant opportunities for innovative therapeutic approaches to tackle orthopedic conditions. Innovations in knee braces and assistive devices mark a new era in medical solutions, enhancing patient comfort and optimizing treatment outcomes. These modern devices are engineered to deliver precise, stable, and reliable support for a spectrum of knee-related issues, spanning from injuries to chronic conditions. This evolution supports healthcare professionals in tailoring interventions according to the unique needs of each patient, thereby advancing personalized treatment options.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Pricing Analysis
Start Up Analysis
Regulatory Landscape
Patent Analysis
Pipeline Analysis
Key Success Factors
Market Attractiveness Index
Degree of Competition
Top Investment Pockets
Ecosystem Mapping

Swollen Knee Treatment Market by Type

Market Overview
Medications
Patient-controlled Analgesia Pumps
Nerve Blocks
Liposomal Bupivacaine
Surgery

Swollen Knee Treatment Market by Medications

Market Overview
Opioids
Corticosteroids
Others

Swollen Knee Treatment Market by Surgery

Market Overview
Arthrocentesis
Arthroscopy
Knee Replacement
- Total Knee Replacement
- Unicompartmental Knee Replacement
- Others

Swollen Knee Treatment Market by End User

Market Overview
Hospitals
Designated Clinics
Ambulatory Surgical Centers
Others

Swollen Knee Treatment Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

腫れた膝治療の市場規模、シェア、成長分析：タイプ別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Swollen Knee Treatment Market Size, Share, Growth Analysis, By Type, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

腫れた膝治療市場：タイプ別

腫れた膝治療市場：医薬品別

腫れた膝治療市場：手術別

腫れた膝治療市場：エンドユーザー別

腫れた膝治療市場規模：地域別